within Pharmacolibrary.Drugs.ATC.C;

model C01CA30
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01CA30</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Metildigoxin in combination with organic nitrates is classified under ATC code C01CA30 and was used for the treatment of heart failure and angina pectoris. Metildigoxin is a cardiac glycoside with positive inotropic effects, while organic nitrates provide vasodilation. This combination therapy is no longer widely used and is considered obsolete in most clinical settings.</p><h4>Pharmacokinetics</h4><p>No specific published pharmacokinetic data available for metildigoxin and organic nitrate combinations as a fixed formulation. Only individual agent data exist, and no population PK studies in combination have been published.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01CA30;
